Amifostine 200 mg/m2 three times weekly vs Amifostine 200 mg/m2 five times weekly
Xerostomia (grade >= 2, 0-4 scale) · Patients receiving radiotherapy on its own or in addition to chemotherapy to the head and neck region
Amifostine 200 mg/m2 three times weekly showed no clear difference in xerostomia (grade >= 2, 0-4 scale) compared with amifostine 200 mg/m2 five times weekly; GRADE not reported.
1 finding from 1 review
- Pharmacological interventions for preventing dry mouth and salivary gland dysfunction following radiotherapy 2017 · Cochrane All outcomes12 months postRTRR 0.94 [0.58, 1.53]1 study · 49 participantsGRADE not reported